2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5 Remdesivir Intermediate COVID-19
Onye nrụpụta Azụmahịa Remdesivir na ihe ndị metụtara ya nwere ogo dị elu
Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
Trimethylsilyl Cyanide CAS 7677-24-9
4-Nitrophenol CAS 100-02-7
2-Ethylbutyl ((S)-(perfluorophenoxy) (phenoxy) phosphoryl) -L-alaninate CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy) phenoxyphosfinyl] -L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S) -2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
Metabolite Remdesivir (GS-441524) CAS 1191237-69-0
Remdesivir N-2 Intermediate CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine CAS 937046-98-5
Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine CAS 159326-68-8
4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Aha Chemical | 2,3,5-Tri-O-benzyl-D-ribonolactone |
Ụdị okwu | 2,3,5-Tri-O-Benzyl-D-Ribono-1,4-Lactone;Remdesivir Intermediate |
Nọmba CAS | 55094-52-5 |
Nọmba CAT | RF-PI301 |
Ọnọdụ Ahịa | Na Akụrụngwa, Mpụta Ihe ruru narị narị kilograms |
Usoro ihe omimi | C26H26O5 |
Ibu molekụla | 418.49 |
Ebe Na-agbaze | 54.0-55.0 ℃ |
Ọnọdụ Nchekwa | Okpomọkụ ụlọ |
Ụdị | Ruifu Chemical |
Ihe | Nkọwapụta |
Ọdịdị | Yellowish ma ọ bụ White siri ike |
Solubility | Soluble na CH2Cl2 na enweghị ike soluble na H2O |
NMR na MS | Kwesịrị ịgbaso |
njirimara | IR na TLC |
Mmiri | ≤1.0% |
Ihe fọdụrụ na mgbanye | ≤0.50% |
Ọdịghị ọcha nke Onye ọ bụla | ≤0.50% |
Ọla dị arọ | ≤50ppm |
HPLC (210nm) | ≥99.0% |
HPLC (ELSD) | ≥99.0% |
Nlele ọkọlọtọ | Standardkpụrụ ụlọ ọrụ |
Ojiji | Ọkara nke Remdesivir (CAS 1809249-37-3) |
ngwugwu: Kalama, Aluminom foil bag, kaadiboodu drum, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ.
Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ọkụ, mmiri mmiri na ụmụ ahụhụ.
2,3,5-Tri-O-benzyl-D-ribonolactone (CAS 55094-52-5) bụ etiti Remdesivir.Remdesivir (CAS 1809249-37-3) bụ ọgwụ mgbochi ọhụụ na klas nke nucleotide analọg, ejiri na ọgwụgwọ COVID-19.Remdesivir (GS-5734) bụ akwụkwọ akụkọ antiviral nucleoside analogue nke na-egbochi nje ịba ọcha n'anya murine (MHV) nwere EC50 yiri SARS-CoV na MERS-CoV.Coronaviruses (CoVs) bụ ezi uche, nje virus RNA nwere otu eriri na-efe efe n'ọtụtụ anụmanụ.N'ime ụmụ mmadụ, a ghọtara CoV dị ka ọ na-ebutekarị oyi na oyi baa ruo mgbe mmalite nke nnukwu ọrịa iku ume iku ume coronavirus (SARS-CoV) na 2002 na Middle East respiratory syndrome coronavirus (MERS-CoV) na 2012 sitere na isi mmalite zoonotic.Remdesivir bụ monophosphoramidate prodrug nke C-adenosine nucleoside analogue GS-441524.N'ime mkpụrụ ndụ ụbụrụ ụbụrụ na-egbu oge (DBT) na-ebute ọrịa MHV, GS-5734 gbochiri MHV karịa GS-441524, na GS-5734 EC50 nke 0.03 M. Ọzọkwa, a na-ekpebi ụkpụrụ EC50 mgbe ọgwụgwọ na GS-441524 na GS-5734 N'ime omenala SARS-CoV- na MERS-CoV-ebutere mmadụ isi ikuku epithelial cell (HAE).